期刊文献+

丙型肝炎病毒相关甲状腺功能障碍发病机制与临床治疗研究进展 被引量:5

Advances in pathogenesis and management of hepatitis C virus-related thyroid dysfunction
原文传递
导出
摘要 丙型肝炎病毒(HCV)相关甲状腺功能障碍是慢性丙型肝炎患者的常见并发症,其临床表现包括Graves病、桥本甲状腺炎、破坏性亚急性甲状腺炎、单纯甲状腺功能的亢进或减低,可伴有或不伴有自身抗体或甲状腺相关抗体水平异常.目前学者认为HCV相关甲状腺功能障碍可能的致病机制,包括旁道激活途径、分子模拟机制、干扰素作用以及特殊位点基因多态造成遗传易感性.目前尚缺乏对HCV相关甲状腺功能障碍的规范临床诊疗标准,对于轻症甲状腺功能障碍主要以观察为主,严重者可依据临床表现选择抗甲状腺药物、左旋甲状腺素、手术或对症治疗.该文总结了HCV相关甲状腺功能障碍的流行病学、临床特点以及发病机制,为临床医师的临床诊疗提供依据. Hepatitis C virus (HCV)-related thyroid dysfunction is a common complication in patients with chronic hepatitis C,including Graves' disease,Hashimoto thyroiditis,destructive subacute thyroiditis,hyperparathyroidism or hypothyroidism,with or without abnormal autoantibodies or thyroidrelated antibodies.The possible pathogenesis of HCV-related thyroid dysfunction includes bystander activation,molecular mimicry,effects of interferon and susceptibility associated with genetic polymorphism on particular locus.By now,there is still no criteria for diagnosis and treatment of HCV-related thyroid dysfunction.For patients with mild HCV-related thyroid dysfunction,observation may be appropriate; and for those with serious symptoms,anti-thyroid drug,levothyrocine,surgery or symptomatic treatment may be applied according to clinical symptoms.This paper gives an overview of the prevalence,clinical characteristics and possible pathogenesis of HCV-related thyroid dysfunction.
出处 《中华临床感染病杂志》 CAS 2014年第3期271-276,共6页 Chinese Journal of Clinical Infectious Diseases
关键词 肝炎 丙型 甲状腺疾病 干扰素类 自身免疫 Hepatitis C Thyroid diseases Interferons Autoimmunity
  • 相关文献

参考文献6

二级参考文献68

共引文献43

同被引文献36

  • 1潘越峻,应若素,范慧敏,张春兰,唐小平.干扰素α治疗慢性肝炎诱发甲状腺功能异常的临床研究[J].中华临床感染病杂志,2008,1(3). 被引量:3
  • 2李坤陶.毒品的种类及危害[J].生物学通报,2007,42(5):11-13. 被引量:11
  • 3陈灏珠,林果为.实用内科学[M].13版.北京:人民卫生出版社,2009:919. 被引量:692
  • 4陆再英,钟南山.内科学[M].7版.人民卫生出版社,2008,1:96. 被引量:28
  • 5中华医学会肝病学分会,中华医学会传染病与寄生虫病学分会.丙型肝炎防治指南[J].中华传染病杂志,2004,22(6):131-136. 被引量:5
  • 6Masood N, Ghori R, MemonA, et al. Frequency of thyroid disorders during interferon and ribavirin therapy in chronic hepatitis C infection [ J ]. J Coil Physicians Surq Pak,2008,18 ( 6 ) : 347 -351. 被引量:1
  • 7Mandac JC, Chaudhry S, Sherman KE, et al. The Clinical and Physiological Spectrum of Interferon - Alpha Induced Thyroiditis: Toward a New Classication [ J ]. Hepatology, 2006,43 ( 4 ) : 661-672. 被引量:1
  • 8Inoue A, Koizumi S, Matsuda A, et al. Graves Hyperthyroidism showing transient hypothyroidism during interferon therapy for chronic hepatitis type C [ J ]. Endocr J,2005,52 ( 3 ) : 293-298. 被引量:1
  • 9Jamil KM, Leedman PJ, Kontorinis N, et al. Interferon - induced thyroid dysfunction in chronic hepatitis C [ J ]. J Gastroenterol Hepatol,2009, 24(6) :1017-1023. 被引量:1
  • 10Armstrong GL,Wasley A,Simard EP,et al.The prevalence of hepatitis C virus infection in the United States,1999 through 2002[J].Ann Intern Med,2006,144(10):705. 被引量:1

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部